Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002314419 | SCV000847974 | likely benign | Inborn genetic diseases | 2018-06-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001655576 | SCV001867626 | benign | not provided | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807323 | SCV002054249 | benign | Coffin-Siris syndrome 1 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001655576 | SCV003250123 | benign | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535781 | SCV004749538 | likely benign | ARID1B-related disorder | 2024-02-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |